We are excited to announce that the first pediatric patient has been dosed in a Phase 2 clinical study of GLM101, which is in development as the first potential disease-modifying treatment for #PMM2CDG. https://lnkd.in/gtZhSd2W #CDGresearch #rarediseases #raredisease #clinicaltrial #clinicaltrials #glycosylation #glycoprotein #glycans #glycosylated #glycoresearch
Congrats, Teppei san!
Congrats! Fantastic news
Project Manager and Scientist
10moCongratulations! This is exciting to hear!